(Press-News.org) JOHANNESBURG, SOUTH AFRICA and SHENZHEN, CHINA - 31.03.23
Akili Labs (Pty) Ltd, a pioneer of cost-effective molecular diagnostics and secure genomic data storage solutions, and BGI Genomics Co. Ltd, the world’s leading integrated solutions provider of precision medicine, today announced the signing of a technology transfer agreement that will provide the Southern region of Africa with clinical-grade sequencing solutions.
"Improving the cost and turnaround time of genetic sequencing services will play a major role in the expansion of precision medicine-driven healthcare in Africa," said Charles F.J. Faul, co-founder and Chief Executive Officer of Akili. "Locally provided services have struggled with capacity restraints and are challenged with local pricing of reagents and equipment. Often, the only solution is to send samples to Europe or the USA, where sequencing is cheaper. However, this comes at a price: the application for export permits can be a lengthy process, and then there is the risk of sample loss or damage during shipping.
“Access to sequencing is only one part of the equation”, said Stuart A. Ali, PhD, Chief Scientific Officer at Akili. “This partnership supplies the first truly Africa-based service to meet our client needs. With this partnership, we can process samples locally in full compliance with regional data protection laws.”
“We are thrilled to see the progress being made in genomics sequencing development in Africa.”, said Ronnie Mao, Business Manager of Southern Africa, BGI Genomics. “With the continent being home to the world's most diverse genomics data, it's crucial that local talent has the tools and resources to further our understanding of clinical genetics, we welcome the initiative to develop localized genomics sequencing capabilities in Africa, with a focus on clinical genetics and improving health outcomes. This will not only benefit the people of Africa but also it's important to enable and empower local talent to lead this effort and bring their unique perspectives to the field. We look forward to seeing the positive impact that this development will have on the health of individuals and communities in Africa.”
About Akili
Akili specializes in cost-effective and accessible diagnostic services through a combination of careful technology selection and process optimization. Aiming for vertical integration to drive precision medicine, our services are supported by a proprietary cloud platform and data is stored using highly secure encryption and compression algorithms. Akili Labs has regional offices in Johannesburg and Cape Town, South Africa, Lusaka, Zambia and Maryland, USA. These locations collectively establish the start of a global network for precision medicine and consumer genetics services.
About BGI Genomics:
BGI Genomics, headquartered in Shenzhen China, is the world’s leading integrated solutions provider of precision medicine. Our services cover over 100 countries and regions, involving more than 2,300 medical institutions. In July 2017, as a subsidiary of BGI Group, BGI Genomics (300676.SZ) was officially listed on the Shenzhen Stock Exchange.
END
Akili Labs and BGI Genomics to deliver their first commercial clinical sequencing facility in Africa
2023-04-06
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Technology advance paves way to more realistic 3D holograms for virtual reality and more
2023-04-06
WASHINGTON — Researchers have developed a new way to create dynamic ultrahigh-density 3D holographic projections. By packing more details into a 3D image, this type of hologram could enable realistic representations of the world around us for use in virtual reality and other applications.
“A 3D hologram can present real 3D scenes with continuous and fine features,” said Lei Gong, who led a research team from the University of Science and Technology of China. “For virtual reality, our method could be used with headset-based holographic displays to greatly improve the viewing angles, which would enhance the 3D viewing experience. ...
Novel tridimensional anticancer agents developed to fight against drug-resistant cancer cells
2023-04-06
A research team co-led by chemists from City University of Hong Kong (CityU) recently discovered novel, highly effective anticancer agents with tridimensional structures, which have high anticancer activity, low toxicity and the ability to overcome drug resistance in cancer cells. The findings help provide a new direction for anticancer drug development.
Cancer has long been a devastating disease, which affects millions of people worldwide. Despite advances in treatment, current anticancer drugs often have limited effectiveness, lack of cancer ...
ASBMB urges NIAID to prioritize DEAI
2023-04-06
The American Society for Biochemistry and Molecular Biology sent recommendations March 30 to the National Institute of Allergy and Infectious Diseases on expanding the institute’s diversity, equity, accessibility and inclusivity activities.
The society recommended, broadly, that the NIAID expand the use of diversity and re-entry grant supplements and better support disabled, LGBTQ+ and other underrepresented scientists.
“Because NIAID is one of the largest NIH institutes, they have ...
How to make better consistency and availability trade-offs in networks
2023-04-06
Imagine you want to withdraw some cash from an ATM. You expect it to show your account balance correctly and process your request quickly. However, network delays make it hard for the system to meet both of these simple expectations at the same time. If an ATM system tries to achieve high “consistency,” meaning that it displays the latest account balance by checking a remote database, it could make you wait or even prevent you from accessing your accounts during busy times. On the other hand, if an ATM system favors “availability,” it could let you access your accounts fast, but risk showing inaccurate information. To avoid undesired results, ...
Science journals integrate Dryad to simplify data deposition and strengthen scientific reproducibility
2023-04-06
The Science family journals have announced a partnership with the nonprofit data repository Dryad that simplifies the process by which authors deposit data underlying new work – a critical step to facilitating data’s routine reuse. The partnership is yet another step taken by the Science journals to ensure data the scientific community requires to verify, replicate and reanalyze new research is openly available.
“Addressing public access to data at scale is a critical challenge,” said Holden Thorp, Editor-in-Chief of the Science family ...
Men and women have different obesity drivers, pointing to the need for tailored interventions
2023-04-06
A new study from UCLA researchers finds sex-specific brain signals that appear to confirm that different drivers lead men and women to develop obesity. The study, appearing in the peer-reviewed journal Brain Communications, combined data from several modes of MRI with patients’ clinical features and personal histories to identify sex-specific mechanisms in the brain underlying obesity.
“We found differences in several of the brain’s networks associated with early life adversity, mental ...
Disparities identified among patients receiving advanced pulmonary support
2023-04-06
Some adults with severe respiratory illness, including women, those with public insurance, and people with fewer financial resources, may be less likely to receive an advanced form of life support known as extracorporeal membrane oxygenation (ECMO). A research team supported by the National Institutes of Health found that adults who received ECMO appeared to skew toward men, people with private health insurance, and those who came from areas with higher median incomes. ECMO helps patients with life-threatening illness or injury breathe by simulating the function of the heart and/or lungs, while giving those organs a chance to rest.
The study published in the Annals of the American ...
Researchers ID biomarkers of response to immunotherapy for kidney cancer
2023-04-06
The number of immune cells in and around kidney tumors, the amount of dead cancer tissue, and mutations to a tumor suppressor gene called PBRM1 form a biomarker signature that can predict — before treatment begins — how well patients with kidney cancer will respond to immunotherapy, according to new research directed by investigators at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy.
In reviews of 136 kidney tumor biopsies taken for previous studies, investigators found that patients who had three positive factors — presence of immune cells in and around tumors, known as tumor-infiltrating immune cells, absence ...
Studying consciousness without affecting it
2023-04-06
Studies of consciousness often run into a common conundrum of science—it’s hard to measure a system without the measurement affecting the system. Researchers assessing consciousness, for instance as volunteers receive anesthesia, typically use spoken commands to see if subjects can still respond, but that sound might keep them awake longer or wake them up sooner than normal. A new study not only validates a way to assess consciousness without external stimulation, it also finds that it may be more precise.
“We want to measure when people make the transition from conscious to unconscious, and vice versa, but as soon as you ask someone to do something, which is the classic ...
New pesticide exposure test developed to protect inexperienced cannabis farmers
2023-04-06
A chemical analyst and expert in micro-extraction at The University of Toledo created a more reliable, robust and efficient way to monitor pesticide exposure and help protect the health and safety of agricultural workers, especially for emerging sectors like the cannabis industry.
Dr. Emanuela Gionfriddo, an assistant professor of analytical chemistry, and Nipunika H. Godage, a Ph.D. candidate in UToledo’s Dr. Nina McClelland Laboratory for Water Chemistry and Environmental Analysis, published research in the journal Analytical and Bioanalytical Chemistry outlining their groundbreaking method that is able to detect 79 pesticide residues in human blood plasma ...